Lv1
70 积分 2023-05-18 加入
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS
8天前
已完结
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results
15天前
已完结
Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma
15天前
已完结
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
15天前
已完结
RNAi-based drug design: considerations and future directions
28天前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
1个月前
已完结
Sensing of tubular flow and renal electrolyte transport
1个月前
已完结
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody–Drug Conjugate for Enhanced Antitumor Efficacy in Solid Tumors
1个月前
已完结
CD98hc controls CNS angiogenesis and blood-brain barrier integrity through localized regulation of the systemic integrin-FAK pathway
1个月前
已完结
Advances and challenges in kidney fibrosis therapeutics
1个月前
已完结
皖公网安备34019202002308
